Emergent BioSolutions Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1,098.45 |
821.90 |
938.50 |
640.18 |
878.60 |
963.20 |
| Przychód Δ r/r |
0.00% |
-25.18% |
14.19% |
-31.79% |
37.24% |
9.63% |
| Przychód (min) |
1,088.46 |
792.81 |
682.30 |
640.18 |
781.93 |
857.22 |
| Przychód (max) |
1,118.42 |
850.99 |
1,194.70 |
640.18 |
973.36 |
1,067.08 |
| EBITDA (średnia) |
29.45 |
22.04 |
25.16 |
17.16 |
23.56 |
25.82 |
| EBIT (średnia) |
-81.14 |
-60.71 |
-69.33 |
-47.29 |
-64.90 |
-71.15 |
| EBIT % |
-7.39% |
-7.39% |
-7.39% |
-7.39% |
-7.39% |
-7.39% |
| Zysk netto (średni) |
-44.28 |
54.59 |
53.46 |
-110.36 |
22.79 |
47.70 |
| Zysk netto % |
-4.03% |
6.64% |
5.70% |
-17.24% |
2.59% |
4.95% |
| EPS (średnia) |
-0.84 |
1.03 |
0.96 |
-2.04 |
0.43 |
0.90 |
| Liczba analityków (Przychody) |
2 |
2 |
2 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
1 |
1 |
1 |
1 |
1 |
| symbol |
EBS |
EBS |
EBS |
EBS |
EBS |
EBS |